Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2) due to risks observed in animal studies (47)
After several months of treatment, patients often achieve weight loss goals and begin transitioning to a maintenance phase
Weight reduction In a Phase 2 obesity trial, the 12-mg dose reached ~24% mean weight loss at 48 weeks
Try to get up and move around every hour
US$ 28.74
US$ 24.28
US$ 25.62
US$ 24.90
US$ 24.22
US$ 22.39
US$ 20.17
